Featured 13F manager
Sanders Capital, LLC Lewis Sanders
West Palm Beach, FL 26 processed 13Fs on this site · 2021 Q3–2026 Q2
- $99.8B
- 47 Positions
- 2026 Q2
- +18.9% QoQ
- Top 5 41.3%
Portfolio
top 5 41.3% · top 10 60.2%
- TSM - Taiwan Semiconductor 12.5%
- GOOG - Alphabet · CL C 9.7%
- AMZN - Amazon 7.0%
- META - Meta Platforms · CL A 6.1%
- MSFT - Microsoft 6.0%
- NVDA - Nvidia 4.5%
- AMAT - Applied Matls 4.4%
- HCA - Hca Healthcare 3.5%
- STX - Seagate 3.4%
- AAPL - Apple 3.1%
- CI - The Cigna Group 2.8%
- DAL - Delta Air Lines 2.7%
- Other 34.3%
AUM over time
Book
| TSM - Taiwan Semiconductor | 11.30% | Reduce −12.2% | 28,060,092 | $337.95 | $9.5B | −3,898,268 | −$229M |
| GOOG - Alphabet · CL C | 9.82% | Reduce −10.0% | 28,733,083 | $286.86 | $8.2B | −3,180,938 | −$1.8B |
| AMZN - Amazon | 7.40% | Add +100.1% | 29,818,675 | $208.27 | $6.2B | +14,918,245 | +$2.8B |
| META - Meta Platforms · CL A | 7.20% | Add +5.2% | 10,564,799 | $572.13 | $6B | +526,625 | −$582M |
| STX - Seagate | 6.02% | Reduce −24.9% | 12,897,201 | $391.76 | $5.1B | −4,283,691 | +$321M |
| MSFT - Microsoft | 5.47% | Add +2.0% | 12,393,692 | $370.17 | $4.6B | +243,477 | −$1.3B |
| HCA - Hca Healthcare | 5.05% | Reduce −14.4% | 8,957,145 | $473.24 | $4.2B | −1,507,023 | −$646M |
| AAPL - Apple | 3.29% | Reduce −0.4% | 10,869,641 | $253.79 | $2.8B | −40,614 | −$207M |
| CI - The Cigna Group | 3.27% | Add +31.9% | 10,290,382 | $266.75 | $2.7B | +2,489,293 | +$598M |
| ACN - Accenture Ireland · CLASS A | 2.65% | Add +2.1% | 11,197,806 | $198.29 | $2.2B | +234,191 | −$721M |
| BAC - Bank of America | 2.62% | Reduce −0.2% | 45,167,159 | $48.75 | $2.2B | −103,869 | −$288M |
| AMAT - Applied Matls | 2.51% | Reduce −30.1% | 6,175,172 | $341.79 | $2.1B | −2,660,789 | −$160M |
| DAL - Delta Air Lines | 2.33% | Reduce −0.4% | 29,467,155 | $66.48 | $2B | −110,659 | −$94M |
| SPY — | 2.26% | Add +42.5% | 2,923,008 | $650.34 | $1.9B | +872,370 | +$503M |
| RTX - Raytheon | 2.16% | Add +0.1% | 9,407,278 | $192.90 | $1.8B | +11,407 | +$91M |
| CRM - Salesforce | 2.12% | Add +10.6% | 9,532,303 | $186.67 | $1.8B | +916,484 | −$503M |
| ELV - Elevance | 2.06% | Add +2.5% | 5,894,303 | $292.75 | $1.7B | +143,438 | −$290M |
| UNH - Unitedhealth Group | 1.92% | Reduce −0.5% | 5,964,685 | $270.59 | $1.6B | −32,457 | −$366M |
| V - VISA · CL A | 1.75% | Add +46.6% | 4,861,653 | $302.24 | $1.5B | +1,546,350 | +$307M |
| UAL - United Airls | 1.67% | Add +0.1% | 15,204,551 | $92.07 | $1.4B | +21,732 | −$298M |
| AZN - Astrazeneca | 1.66% | New | 7,065,628 | $197.22 | $1.4B | +7,065,628 | +$1.4B |
| NOC - Northrop Grumman | 1.52% | Reduce −1.9% | 1,867,227 | $682.24 | $1.3B | −36,176 | +$189M |
| NVDA - Nvidia | 1.48% | New | 7,125,506 | $174.40 | $1.2B | +7,125,506 | +$1.2B |
| GD - General Dynamics | 1.48% | Reduce −1.6% | 3,617,244 | $343.22 | $1.2B | −60,380 | +$3M |
| CME - CME Group | 1.46% | Reduce −0.4% | 4,161,190 | $295.35 | $1.2B | −16,325 | +$88M |
| MA - Mastercard · CL A | 1.41% | Add +52.4% | 2,360,429 | $499.66 | $1.2B | +811,841 | +$295M |
| JPM - Jpmorgan Chase & | 1.37% | Reduce −9.5% | 3,896,565 | $294.16 | $1.1B | −408,928 | −$241M |
| ULTA - Ulta Beauty | 1.19% | Add +51.0% | 1,908,139 | $522.71 | $997M | +644,403 | +$233M |
| PG - Procter & Gamble | 1.16% | Reduce −0.4% | 6,751,488 | $144.44 | $975M | −24,198 | +$4M |
| PDD - Pinduoduo | 0.99% | Reduce −0.3% | 8,091,801 | $102.18 | $827M | −20,526 | −$93M |
| VEU — | 0.89% | Add +54.4% | 9,979,709 | $75.10 | $749M | +3,516,630 | +$274M |
| LMT - Lockheed Martin | 0.82% | Reduce −0.2% | 1,141,023 | $604.39 | $690M | −2,204 | +$137M |
| TCOM - Trip Group | 0.63% | Add +7.6% | 10,640,774 | $49.79 | $530M | +750,137 | −$181M |
| PEP - Pepsico | 0.33% | Reduce −58.2% | 1,773,582 | $155.29 | $275M | −2,471,840 | −$334M |
| HSBC — | 0.28% | Reduce −2.8% | 2,807,030 | $82.49 | $232M | −80,440 | +$4M |
| ABT - Abbott Laboratories | 0.14% | Reduce −2.6% | 1,121,205 | $102.67 | $115M | −30,380 | −$29M |
| ABBV - Abbvie | 0.13% | Reduce −2.9% | 516,593 | $217.49 | $112M | −15,570 | −$9M |
| TFC - Truist Finl | 0.11% | Reduce −3.1% | 2,037,822 | $45.97 | $94M | −64,800 | −$10M |
| BKNG - Booking | 0.06% | Add +0.7% | 299,473 | $168.41 | $50M | +2,017 | −$1.5B |
| SHG — | 0.01% | Reduce −2.5% | 153,626 | $61.32 | $9M | −3,860 | +$974K |
| UL - Unilever | 0.01% | Reduce −6.9% | 91,535 | $56.97 | $5M | −6,800 | −$1M |
| ING - Ing Groep | 0.00% | Reduce −9.7% | 115,885 | $26.05 | $3M | −12,500 | −$550K |
| NWG - Natwest Group | 0.00% | Reduce −9.9% | 185,064 | $14.90 | $3M | −20,400 | −$838K |
| SYF - Synchrony Financial | 0.00% | Reduce −4.9% | 18,867 | $68.02 | $1M | −970 | −$372K |
Exits / last held
not current holdings · last reported size, unchanged · gone vs 2025 Q4
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| AZNN — | 1.50% | Exit | 0 | $91.93 | $1.3B | −14,139,408 | −$1.3B |
| FISV - Fiserv | 0.18% | Exit | 0 | $67.17 | $154M | −2,292,304 | −$154M |
Filings history
20 periods · normalized AUM · open a period for holdings
| Period | Holdings | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 47 | $99.8B | +18.9% | 13F-HR | 8/10/2026 | 000117266126003204 |
| 2026 Q1 | 44 | $83.9B | −3.3% | 13F-HR | 5/14/2026 | 000117266126001934 |
| 2025 Q4 | 44 | $86.8B | +6.8% | 13F-HR | 2/13/2026 | 000117266126000730 |
| 2025 Q3 | 47 | $81.3B | +9.1% | 13F-HR | 11/13/2025 | 000117266125004770 |
| 2025 Q2 | 47 | $74.5B | +11.3% | 13F-HR | 8/8/2025 | 000117266125002985 |
| 2025 Q1 | 47 | $66.9B | −2.2% | 13F-HR | 5/14/2025 | 000117266125001867 |
| 2024 Q4 | 46 | $68.4B | −0.9% | 13F-HR | 2/13/2025 | 000117266125000773 |
| 2024 Q3 | 45 | $69B | +5.7% | 13F-HR | 11/13/2024 | 000117266124004606 |
| 2024 Q2 | 45 | $65.3B | +9.0% | 13F-HR | 8/9/2024 | 000117266124003172 |
| 2024 Q1 | 42 | $59.9B | +10.7% | 13F-HR | 5/10/2024 | 000117266124002130 |
| 2023 Q4 | 44 | $54.1B | +14.3% | 13F-HR | 2/12/2024 | 000117266124000707 |
| 2023 Q3 | 44 | $47.3B | −1.1% | 13F-HR | 11/9/2023 | 000117266123003699 |
| 2023 Q2 | 49 | $47.9B | +13.4% | 13F-HR | 8/11/2023 | 000117266123002910 |
| 2023 Q1 | 48 | $42.2B | +10.6% | 13F-HR | 5/10/2023 | 000117266123001957 |
| 2022 Q4 | 46 | $38.1B | +4.9% | 13F-HR | 2/10/2023 | 000117266123000604 |
| 2022 Q3 | 42 | $36.4B | — | new holds | 2/17/2023 | 000117266123001499 |
| 2022 Q3 | 41 | $36.4B | −8.0% | 13F-HR | 11/14/2022 | 000117266122002493 |
| 2022 Q2 | 42 | $39.5B | −21.3% | 13F-HR | 8/12/2022 | 000117266122001826 |
| 2022 Q1 | 44 | $46B | — | RESTATEMENT | 8/24/2022 | 000117266122002034 |
| 2022 Q1 | 44 | $50.2B | −6.7% | 13F-HR | 5/20/2022 | 000150809722000006 |
| 2021 Q4 | 44 | $49B | — | RESTATEMENT | 8/25/2022 | 000117266122002039 |
| 2021 Q4 | 44 | $53.8B | — | RESTATEMENT | 5/23/2022 | 000150809722000008 |
| 2021 Q4 | 44 | $53.8B | +11.3% | 13F-HR | 2/14/2022 | 000150809722000002 |
| 2021 Q3 | 45 | $44.1B | — | RESTATEMENT | 8/24/2022 | 000117266122002036 |
| 2021 Q3 | 45 | $48.3B | — | RESTATEMENT | 5/24/2022 | 000150809722000016 |
| 2021 Q3 | 45 | $48.3B | — | 13F-HR | 11/12/2021 | 000150809721000005 |
About
Sanders Capital, LLC
26 processed 13Fs on this site · 2021 Q3–2026 Q2